Vape manufacturers have long been accused of marketing to teens with flavors like mango and cotton candy. Now vaping opponents say vape manufacturers are exploiting the coronavirus with face mask and hand sanitizer giveaways and #COVID-19 discounts. One maker of disposable vapes, Bidi Vapor, declared on Instagram: “A Bidi Stick a day keeps the pulmonologist away.”
The national Campaign for Tobacco-Free Kids says the tactics are hypocritical. Its president, Matthew L. Myers, said it’s imperative that young people quit vaping to avoid being susceptible to COVID-19. “Never before in our history has it been more important for young people to have healthy lungs,’’ Myers said.
Joseph Deane had been drug free for months before he overdosed in the bathroom of a restaurant in New Haven last December. He couldn’t resist when his dealer offered drugs. Unfortunately, the dope turned out to be fentanyl. Deane, just 23 years old, had been fighting addiction for years, but fentanyl, a synthetic opioid, took his life because it’s 50 to 100 times more powerful than heroin. After months without drugs, his body couldn’t handle it.
After being rejected twice, a Connecticut Army veteran has been awarded federal disability benefits for terminal brain cancer he contends was caused by exposure to open burn pits in Afghanistan. Peter Antioho, 33, of Berlin, had to walk daily through heavy smoke emanating from burn pits as he performed his job as second in command on his base in 2012. A variety of items, including human and animal waste, plastic, ammunition and batteries were burned with diesel fuel 24 hours a day in open pits. He was diagnosed with glioblastoma multiforme brain cancer two years ago. (The Conn.
Slowly—but perhaps surely—the country is beginning to address maternal mortality, both through legislation and through initiatives on the part of health care providers. This is critical. We have lost countless women to pregnancy and childbirth, and the majority of those deaths didn’t have to happen. This holds true especially for mothers of color. Black and American Indian/Alaska Native women are about three times as likely to die from pregnancy as white women, according to a study released earlier this month by the Centers for Disease Control and Prevention.
Veterans’ mental health and housing improved when they accessed free legal services in a Veterans Affairs facility, according to a study of veterans in Connecticut and New York City. The more legal services they had, the better they fared, experiencing reduced symptoms of Post-Traumatic Stress Disorder (PTSD) and psychosis, spending less money on abused substances and having better housing situations, the study found. In addition, the study concluded that mental health was improved even if veterans lost their legal battles. The study analyzed the legal/medical partnerships between the nonprofit Connecticut Veterans Legal Center (CVLC) and VA Connecticut Healthcare and between New York Legal Assistance and two VA hospitals. It looked at free legal help given to 950 veterans from 2014 through 2016 and its effects on the mental health, housing, and income of 148 of those veterans followed closely for a year.
Frustrated by Pentagon efforts, Connecticut groups that work with veterans have informed some 1,500 veterans that they can apply for upgrades of “bad paper” military discharge statuses if they have been diagnosed with Post Traumatic Stress Disorder (PTSD). Although tens of thousands of veterans nationwide are eligible to apply for PTSD-related upgrades, just 1,180 have done so, according to figures provided by the Pentagon to the Yale Law School Veterans Legal Services Clinic. In 2014, then Defense Secretary Chuck Hagel issued a policy to make it easier for veterans with PTSD to upgrade their discharge statuses and become eligible for veterans’ benefits. “Most people don’t know about it,” said Olivia Horton, a Yale law student, working on the project to contact Connecticut veterans by mail. She said frustration with the Pentagon’s public outreach “was the impetus” to contact veterans directly.
Now is the time to repeal a 40-year-old law that perpetuates inequality among women. The Hyde Amendment, which bans the use of federal funds to pay for abortions except in certain circumstances, is unfair. The amendment targets women who rely on Medicaid for their health care coverage. According to the federal Centers for Medicare and Medicaid Services, roughly two out of three adult women enrolled in Medicaid are between the ages of 19 and 44—the reproductive years. Abortions can run upward of $1,000, which places the (legal) procedure out of reach for most women living in poverty.
Michael Baudin of Manchester retired eight years ago after a career in auto repair, but now the 76-year-old is back working part time as a driver so he can afford prescription medications. “Every year premiums go up and my co-pay is increasing,” he said. “I take medication for cholesterol, hypertension, heart, prostate and digestion. My wife quit her job due to health issues and her medication is expensive too.”
Baudin says his out-of-pocket cost for a 90-day supply of just one drug, Creon from AbbVie Inc., which he takes for digestion, is $100. The drug does not have a generic equivalent.
In hospitals across Connecticut and nationwide, workarounds to compensate for medication shortages are daily routines for treating patients – and health experts say it’s not about to change any time soon. Some acute-care drugs in short supply nationally are antibiotics, antipsychotics, intravenous saline, and morphine, according to the most recent shortage list from the U.S. Food and Drug Administration. In Connecticut, hospital officials say they are turning to alternative drugs, rationing supplies, or seeking new suppliers to work around the shortages. At St. Francis Hospital and Medical Center in Hartford, Dr. C. Steven Wolf, chief of emergency medicine, said doctors most recently have been dealing with shortages of dextrose, used to treat dehydration and low blood sugar, as well as intravenous saline and other basic medications.
Five Connecticut physicians have received letters from the U.S. Food and Drug Administration (FDA) alleging that they may have purchased unapproved drugs that put patients at risk of adverse health consequences, documents obtained by C-HIT show. The FDA documents show the five doctors were alerted as part of a wide-reaching federal probe involving Gallant Pharma International Inc., which sold more than $12.4 million in unapproved chemotherapy and injectable cosmetic drugs in the United States before the government shut down the operation in 2013. The letters to the doctors, dated April 1, 2015, say that “In addition to putting patients at risk, receiving misbranded or adulterated drugs and devices in interstate commerce and delivering or offering to deliver those drugs and devices to (or use on) others violates federal law.”
None of the doctors has been charged with wrongdoing, and only one acknowledged receiving the letter from the FDA. The case comes to light as drug companies and pharmacies are urging Congress and law enforcement officials to crack down on an increasing number of dangerous unapproved and counterfeit drugs being sold to doctors and consumers nationwide. Sales of counterfeit drugs and drugs not approved by FDA have soared into a multi-billion dollar industry with the growth of the Internet, and drug companies say efforts by governments to tackle illegal online drug sales are not sufficient.